clinical trial · NCT04208087
PK and Safety of SI-722 in IC/BPS
Interstitial CystitisBladder Pain SyndromeSI-722Placebo
brief summary
This study is designed randomized, double-blind, placebo-controlled trial in Interstitial Cystitis/Bladder Pain Syndrome patients.
started
Mar 30, 2020
primary completion
Jan 12, 2021
completion
Jan 12, 2021
last updated
Dec 29, 2023
official title
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of SI-722 Intravesical Instillation in Interstitial Cystitis/Bladder Pain Syndrome Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol